4th Quarter - Amendment

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,620,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2017 $1,630,000 Replaced
4th Quarter - Amendment (this page) Jan 20, 2017 $1,620,000 Replaced
4th Quarter - Amendment Apr 20, 2017 $1,640,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
GREGG HAIFLEY —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
CAROLINE POWERS —
RICHARD WOODRUFF —

Contacted: State, Dept of (DOS); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); SENATE; White House Office; Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Centers For Disease Control & Prevention (CDC)

Health Issues HCR

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
MATTHEW CASTON —
LAUREN COATOAM —
GREGG HAIFLEY —
GRETA JOHNSON —
KATRINA KAMM —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MAGGIE OSBORNE —
MATTHEW PHELAN —
CAROLINE POWERS —
DAVID PUGACH —
EMILY WHITE —
RICHARD WOODRUFF —

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Labor, Dept of (DOL); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); White House Office; SENATE; U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); Food & Drug Administration (FDA)

Bills named: S. 705 (114th), H.R. 953 (114th), H.R. 5003 (114th), S. 2748 (114th), H.R. 716 (114th), H.R. 1608 (114th), S. 1566 (114th), H.R. 2191 (114th), S. 2943 (114th), S. 524 (114th), H.R. 2017 (114th), H.R. 3119 (114th), S. 3077 (114th), H.R. 644 (114th), H.R. 2739 (114th), S. 1170 (114th), H.R. 2846 (114th), S. 2787 (114th), S. 540 (114th), S. 1014 (114th), S. 2217 (114th), H.R. 5475 (114th), H.R. 3381 (114th), S. 370 (114th), S. 1883 (114th), S. 3136 (114th)

Medicare/Medicaid MMM

Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
KATRINA KAMM —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MATTHEW PHELAN —
CAROLINE POWERS —
EMILY WHITE —
RICHARD WOODRUFF —

Contacted: Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); White House Office; State, Dept of (DOS); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 624 (114th), H.R. 1220 (114th), H.R. 1190 (114th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on issues relating to NIH and cancer moonshot funding in the context of H.R. 2028, the Continuing and Security Assistance Appropriations Act; and, H.R. 34, the 21st Century Cures Act. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation, the House companion draft Appropriations bill, and the Continuing Resolution for FY17 enacted prior to October 1, 2016.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON —
OKEYSHA BROOKS-COLEY —
MATTHEW CASTON —
LAUREN COATOAM —
GREGG HAIFLEY —
PAUL HOLMES —
GRETA JOHNSON —
KATRINA KAMM —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MAGGIE OSBORNE —
MATTHEW PHELAN —
CAROLINE POWERS —
DAVID PUGACH —
EMILY WHITE —
RICHARD WOODRUFF —

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); White House Office; Labor, Dept of (DOL); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 34 (114th), H.R. 2028 (114th), S. 3117 (114th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
GRETA JOHNSON —
KATRINA KAMM —
RACHEL MARCUS Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MATTHEW PHELAN —
CAROLINE POWERS —
DAVID PUGACH —
RICHARD WOODRUFF —

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); White House Office; State, Dept of (DOS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS)

Bills named: S. 430 (114th), S. 1129 (114th), S. 450 (114th), H.R. 478 (114th), H.R. 3042 (114th), H.R. 1749 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.